Validation of Biomarkers for Prostate Cancer Prognosis

Abstract

The most significant challenge in managing localized prostate cancer is the decision of whether or not it needs to be treated. Nearly half of prostate cancers diagnosed in the U.S. fall into the low or very low risk category and have little likelihood of causing death. However, it is well known that a significant fraction of low risk cases are misclassified and actually have occult high-risk features or are destined to progress to high-risk disease. Therefore a critical need in localized prostate cancer is the development of biomarkers that predict occult or incipient aggressive disease in the low-risk population.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Nov 01, 2015
Accession Number
AD1008724

Entities

People

  • Ziding Feng

Organizations

  • University of Texas at Austin

Tags

DTIC Thesaurus Topics

  • Biological Markers
  • Biological Staining And Labeling
  • Biomedical Research
  • Cancer
  • Data Analysis
  • Department Of Defense
  • Diseases And Disorders
  • Genitalia
  • Information Science
  • Medical Personnel
  • Metastasis
  • Neoplasms
  • Prostate
  • Prostate Cancer
  • Statistical Analysis
  • Tissues
  • Validation

Readers

  • Prostate Cancer Biology.
  • Systems Analysis and Design
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.